OR52N5
gene geneOn this page
Also known as OR52N5Q
Summary
OR52N5 (olfactory receptor family 52 subfamily N member 5, HGNC:15231) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 52N5 (Q8NH56). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390075 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_001385662
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15231 |
| Approved symbol | OR52N5 |
| Name | olfactory receptor family 52 subfamily N member 5 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OR52N5Q |
| Ensembl gene | ENSG00000181009 |
| Ensembl biotype | protein_coding |
| Entrez | 390075 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000317093, ENST00000641181
RefSeq mRNA: 2 — MANE Select: NM_001385662
NM_001001922, NM_001385662
CCDS: CCDS31397
Canonical transcript exons
ENST00000641181 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812152 | 5781533 | 5781756 |
| ENSE00003812318 | 5776165 | 5778657 |
| ENSE00003813160 | 5783295 | 5783355 |
Expression profiles
Bgee: expression breadth broad, 23 present calls, max score 57.73.
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 57.73 | gold quality |
| calcaneal tendon | UBERON:0003701 | 44.28 | silver quality |
| colonic epithelium | UBERON:0000397 | 42.50 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 41.70 | silver quality |
| sural nerve | UBERON:0015488 | 41.10 | silver quality |
| bone marrow cell | CL:0002092 | 40.39 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 39.79 | silver quality |
| placenta | UBERON:0001987 | 37.12 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| omental fat pad | UBERON:0010414 | 35.58 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 34.98 | gold quality |
| left uterine tube | UBERON:0001303 | 33.76 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| muscle tissue | UBERON:0002385 | 32.27 | gold quality |
| monocyte | CL:0000576 | 31.30 | gold quality |
| endometrium | UBERON:0001295 | 31.06 | gold quality |
| leukocyte | CL:0000738 | 30.96 | gold quality |
| tonsil | UBERON:0002372 | 30.63 | gold quality |
| adipose tissue | UBERON:0001013 | 30.22 | gold quality |
| fallopian tube | UBERON:0003889 | 29.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.34 | gold quality |
| adrenal tissue | UBERON:0018303 | 29.10 | gold quality |
| gall bladder | UBERON:0002110 | 29.08 | silver quality |
| corpus callosum | UBERON:0002336 | 29.03 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| blood | UBERON:0000178 | 28.04 | gold quality |
| urinary bladder | UBERON:0001255 | 27.97 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.60 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or52n5 | ENSMUSG00000073916 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 52N5 — Q8NH56 (reviewed: Q8NH56)
Alternative names: Olfactory receptor OR11-62
All UniProt accessions (2): A0A126GVK9, Q8NH56
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001001922, NP_001372591* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (18 total): topological domain 8, transmembrane region 7, chain 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NH56-F1 | 85.37 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 106–198
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 16 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, chr11p15
GO Biological Process (5): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), nervous system process (GO:0050877), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| system process | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
170 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR52N5 | RALYL | Q86SE5 | 711 |
| OR52N5 | OVCH2 | Q7RTZ1 | 645 |
| OR52N5 | CNTN5 | O94779 | 491 |
| OR52N5 | HNRNPCL3 | B7ZW38 | 475 |
| OR52N5 | HNRNPCL2 | B2RXH8 | 475 |
| OR52N5 | TIGD3 | Q6B0B8 | 474 |
| OR52N5 | ADGRF3 | Q8IZF5 | 419 |
| OR52N5 | SERHL2 | Q9H4I8 | 417 |
| OR52N5 | SYT6 | Q5T7P8 | 405 |
| OR52N5 | TTLL1 | O95922 | 403 |
| OR52N5 | CRNKL1 | Q9BZJ0 | 389 |
| OR52N5 | SLC25A17 | O43808 | 389 |
| OR52N5 | TRIP11 | Q15643 | 379 |
| OR52N5 | A4GALT | Q9NPC4 | 362 |
| OR52N5 | HNRNPCL1 | O60812 | 355 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR52N5 | ART1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): SHARPIN (Affinity Capture-MS), CD226 (Affinity Capture-MS), ABHD8 (Affinity Capture-MS), ART1 (Affinity Capture-MS)
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
212 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5777948:CAAAG:C | acceptor_gain | 0.9800 |
| 11:5777952:G:GC | acceptor_gain | 0.9600 |
| 11:5777952:G:C | acceptor_gain | 0.9500 |
| 11:5777949:A:T | acceptor_gain | 0.9200 |
| 11:5777940:T:TC | acceptor_gain | 0.8300 |
| 11:5777940:T:C | acceptor_gain | 0.7700 |
| 11:5777954:G:C | acceptor_gain | 0.7600 |
| 11:5778588:G:C | donor_gain | 0.7600 |
| 11:5778643:T:A | donor_gain | 0.7600 |
| 11:5777954:G:GC | acceptor_gain | 0.7500 |
| 11:5778549:T:A | donor_gain | 0.6900 |
| 11:5778544:CT:C | donor_gain | 0.6800 |
| 11:5778593:A:C | donor_gain | 0.6800 |
| 11:5778120:A:C | donor_gain | 0.6500 |
| 11:5777938:CCT:C | acceptor_gain | 0.6300 |
| 11:5778543:A:AC | donor_gain | 0.6300 |
| 11:5778544:C:CC | donor_gain | 0.6300 |
| 11:5777939:C:CC | acceptor_gain | 0.6100 |
| 11:5777967:A:C | acceptor_gain | 0.6100 |
| 11:5778510:A:C | donor_gain | 0.6100 |
| 11:5778538:CAT:C | donor_gain | 0.6100 |
| 11:5777935:CTGC:C | acceptor_gain | 0.5900 |
| 11:5778537:A:AC | donor_gain | 0.5800 |
| 11:5778538:C:CC | donor_gain | 0.5800 |
| 11:5778055:C:CT | donor_gain | 0.5700 |
| 11:5778056:T:TT | donor_gain | 0.5700 |
| 11:5778635:T:A | donor_gain | 0.5700 |
| 11:5777936:TGC:T | acceptor_gain | 0.5600 |
| 11:5778118:TA:T | donor_gain | 0.5600 |
| 11:5778119:AA:A | donor_gain | 0.5600 |
AlphaMissense
2133 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5778104:G:C | F177L | 0.808 |
| 11:5778104:G:T | F177L | 0.808 |
| 11:5778106:A:G | F177L | 0.808 |
| 11:5777816:A:C | F273L | 0.766 |
| 11:5777816:A:T | F273L | 0.766 |
| 11:5777818:A:G | F273L | 0.766 |
| 11:5778302:G:C | F111L | 0.745 |
| 11:5778302:G:T | F111L | 0.745 |
| 11:5778304:A:G | F111L | 0.745 |
| 11:5778575:A:C | F20L | 0.681 |
| 11:5778575:A:T | F20L | 0.681 |
| 11:5778577:A:G | F20L | 0.681 |
| 11:5778326:G:C | F103L | 0.677 |
| 11:5778326:G:T | F103L | 0.677 |
| 11:5778328:A:G | F103L | 0.677 |
| 11:5777831:G:C | F268L | 0.660 |
| 11:5777831:G:T | F268L | 0.660 |
| 11:5777833:A:G | F268L | 0.660 |
| 11:5778347:G:C | F96L | 0.650 |
| 11:5778347:G:T | F96L | 0.650 |
| 11:5778349:A:G | F96L | 0.650 |
| 11:5777894:G:C | F247L | 0.649 |
| 11:5777894:G:T | F247L | 0.649 |
| 11:5777896:A:G | F247L | 0.649 |
| 11:5778353:G:C | F94L | 0.647 |
| 11:5778353:G:T | F94L | 0.647 |
| 11:5778355:A:G | F94L | 0.647 |
| 11:5778535:A:G | W34R | 0.641 |
| 11:5778535:A:T | W34R | 0.641 |
| 11:5778517:A:G | C40R | 0.632 |
dbSNP variants (sampled 300 via entrez): RS1000163797 (11:5783933 C>A), RS1000495427 (11:5782719 C>T), RS1001689012 (11:5781012 A>G), RS1001790192 (11:5778654 C>T), RS1002452738 (11:5783138 G>A), RS1003058495 (11:5783258 G>C), RS1003065940 (11:5777154 T>A), RS1003703453 (11:5784208 G>A,C), RS1004875153 (11:5779536 CT>C), RS1005478797 (11:5776213 T>C), RS1005620482 (11:5783509 A>G), RS1005755663 (11:5775875 A>T), RS1006851766 (11:5784114 C>A), RS1006964824 (11:5776656 T>C), RS1007092221 (11:5783903 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| CGP 52608 | affects binding, increases reaction | 1 |
| MT19c compound | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.